Maito, Sahiros B.

HRN: 24-38-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2024
CEFTAZIDIME 1GM (VIAL)
01/15/2024
01/23/2024
IV
1gram
Q8hrs
CAP-MR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: